IL-2/LAK cells

IL-2/LAK cells

Interleukin-2/Lymphokine-activated killer cells NK cells that have been activated by co-incubating in IL-2 and injected into cancer Pts in a therapeutic modality known as adoptive immunotherapy, which may evoke temporary tumor regression in non-Hodgkin's lymphoma, melanoma, colorectal CA, and renal cell CA, and induce regression of hepatic and pulmonary metastases Adverse effects Pulmonary edema, CHF